Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q2 2017 Earnings

21AugExpected
Q3 2016
Q4 2016
Q1 2017
Q2 2017
-4,215
-2,810.33
-1,405.66
-0.99

Details

Expected EPS
-2970
Actual EPS
-2280
Surprise EPS
690
Surprise Percent
+23.23%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -2280 per share for Q2 2017.

0 Comments

Share your thoughts